A Bright Solution for Dry Eyes

Lumenis’ patented technology OPT™ (Optimal Pulse Technology) transforms the use of light and allows targeted, uniform, precise, and controlled treatment. Specifically designed for the delicate area below the eye, OPT™ safely and effectively breaks the vicious cycle of inflammation associated with dry eye.

OptiLIGHT is a multi-factorial treatment for a multi-factorial disease. It addresses the disease by reducing major sources of inflammation leading to dry eye disease such as abnormal blood vessels, Demodex mites, and pro-inflammatory agents. OptiLIGHT restores the function of meibomian glands and delays evaporation of the tear film.

Treatment protocol typically consists of 4 sessions, at 2 to 4 weeks apart:

• During treatment, your practitioner will cover your eyes with shields and apply a thin layer of coupling gel on the treatment area.
• During treatment, light is applied on the skin below the eyes, most patients report minimal discomfort.
• OptiLIGHT is followed by meibomian gland expression.
• Each session takes only 10-15 minutes. There is no downtime, you can resume your daily activities immediately.

Patients typically report improvement after 2 to 3 treatments. For optimal results, 4 sessions are advised. To ensure long-term results, a maintenance session is recommended every 6-12 months.

You may experience some redness immediately following treatment. This will usually disappear within a few hours. You can return to your daily activities and apply makeup straight away in most cases. You will be advised to stay out of direct sunlight for a few days and to apply sunscreen.

Potential risks and side effects of using OptiLIGHT on your skin may include pain/ discomfort, damage to natural skin texture, change of pigmentation, scaring, excessive edema, fragile skin, bruising, burns, pruritus and xerosis. You should consult with your physician about these risks and whether treatment with OptiLIGHT is suitable for you.

Treatment with OptiLIGHT is contraindicated for patients with the following conditions in the treatment area:

Ocular surgery or eyelid surgery or Neuro-paralysis within 6 months prior to the first treatment;
Uncontrolled eye disorders affecting the ocular surface;
Pre-cancerous lesions, skin cancer or pigmented lesions in the planned treatment area;
Uncontrolled infections or uncontrolled immunosuppressive diseases;
Recent Ocular infections;
Prior history of cold sores or rashes in the perioral area, including: Herpes simplex 1 u0026amp; 2, Systemic Lupus erythematosus and porphyria;
Use of photosensitive medication and/or herbs that may cause sensitivity within 3 months prior to the first IPL session;
Recent radiation therapy to the head or neck or planned radiation therapy;
Recent treatment with a chemotherapeutic agent or planned chemotherapy;
History of migraines, seizures or epilepsy.